Bone News and Research

RSS

IVAX Diagnostics second quarter 2010 operating expenses decrease 11.9%

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the quarter ended June 30, 2010.

17 Aug 2010

$Study finds first clue that links childhood obesity to skeletal fractures$

Study finds first clue that links childhood obesity to skeletal fractures

Children at risk for diabetes before they reach puberty also appear to be at risk for weak bones, Medical College of Georgia researchers report.

16 Aug 2010

Orthofix launches FUSION XT knee brace with new AirTech system

Orthofix International announced today that its Sports Medicine Division, Breg, has launched the FUSION® XT knee brace with its innovative new AirTech™ system. Designed to improve comfort and fit, AirTech is a complete system of air mesh vents and grooved channel frame pads that increase airflow throughout the brace. The system allows cool air in and moves warm air and moisture away from the skin, improving patient comfort. The new pad technology is also designed to reduce pinching and help alleviate pressure points.

16 Aug 2010

NeoStem second-quarter revenues increase 26% to $19.4 million

NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.

16 Aug 2010

Interleukin Genetics transfers stock trading from NYSE Amex to OTCQB Marketplace

Interleukin Genetics, Inc. today announced that trading of shares of the Company's common stock will be transferred from the NYSE Amex to the OTCQB™ Marketplace effective today, August 16, 2010. Investors in the Company can trade the stock easily in this marketplace, where Interleukin Genetics' symbol will now be ILIU.

16 Aug 2010

Serum hormones, bone remodeling markers in bears could help create model for preventing osteoporosis: Study

Bears hibernate all winter, yet when they awaken in the spring, their bones are as strong as ever. Human beings don't hibernate, but their bones do degenerate as they grow older and when they aren't being used. Those who are bedridden for any length of time, even astronauts in the low- or no-gravity conditions of outer space, face the perils of osteoporosis.

16 Aug 2010

Interventional Spine completes another successful surgery with PERPOS Percutaneous Cervical System

Interventional Spine, Inc. today announced the completion of another successful surgery with the unique PERPOS Percutaneous Cervical System for the treatment of neck pain.

16 Aug 2010

Exercise can ease arthritis pain

People with arthritis who exercise have less pain, more energy, improved sleep, and better day-to-day function, according to the American College of Rheumatology.

16 Aug 2010

New T cell engineering approach can improve success rate of immune-cell therapies

Clinical trials using patients' own immune cells to target tumors have yielded promising results. However, this approach usually works only if the patients also receive large doses of drugs designed to help immune cells multiply rapidly, and those drugs have life-threatening side effects. Now a team of MIT engineers has devised a way to deliver the necessary drugs by smuggling them on the backs of the cells sent in to fight the tumor. That way, the drugs reach only their intended targets, greatly reducing the risk to the patient.

16 Aug 2010

Fertility preservation may be unsafe for leukemia patients: Study

Although the use of ovarian tissue cryopreservation and transplantation has lead to 13 live births in women with lymphoma or solid tumors, this method of fertility preservation may be unsafe for patients with leukemia, according to a recent study published online in Blood, the journal of the American Society of Hematology.

16 Aug 2010

CD31 positive cells have potential for treating peripheral artery disease: Research

Isolating cells from a patient's blood or bone marrow that nourish blood vessels may be a safer and less arduous route to treatment of cardiovascular disease than obtaining rare stem cells, according to research from Emory University School of Medicine. In recent clinical trials, doctors in several countries have tested the ability of a patient's bone marrow cells to repair damage, such as heart attacks and peripheral artery disease, created by problems of blood flow.

16 Aug 2010

Four Mass. hospitals investigate trashing of patient health records, Calif. employers worry about workers using marijuana on job

"Four Massachusetts community hospitals are investigating how thousands of patient health records, some containing Social Security numbers and sensitive medical diagnoses, ended up in a pile at a public dump. The unshredded records included pathology reports with patients' names, addresses, and results of breast, bone, and skin cancer tests, as well as the results of lab work following miscarriages. By law, medical records and documents containing personal identifying information must be disposed of in a way that protects privacy, and leaving them at a dump is probably illegal, privacy lawyers and hospital officials said" (Kowalczyk, 8/13).

13 Aug 2010

SANUWAVE second-quarter revenues decrease to $117,000

SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, today reported financial results for the three and six months ended June 30, 2010 and provided a business update.

13 Aug 2010

EUROPEAN BIOTECHNICA AWARD finalists announced

The names of the finalists in this year's EUROPEAN BIOTECHNICA AWARD have been announced. The companies Addex Pharmaceuticals (Switzerland), Apeiron Biologics (Austria) and Galapagos Genomics (Belgium) have made it through to the final round.

13 Aug 2010

Benvenue Medical commences treatment in U.S. with Blazer Vertebral Augmentation System

Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced today that it has treated the first patient in the United States with the Blazer Vertebral Augmentation System - a new device for the treatment of vertebral compression fractures (VCFs). The case was performed by Francis Facchini, M.D., partner, VIR Chicago, at Adventist GlenOaks Hospital in Glendale Heights, Illinois.

13 Aug 2010

Humanetics Corporation secures license to provide treatment for ionizing radiation exposure

In a move likely to secure its place as a leading provider of medical radiation countermeasures, Humanetics Corporation today announced that it has secured exclusive worldwide licenses to two new treatments that provide short and long-term post-exposure protection from ionizing radiation acquired during a terrorist act, nuclear or radiological attack or accident, as part of cancer radiotherapy or even during routine diagnostic CT scans.

13 Aug 2010

Interleukin Genetics second-quarter net loss from continuing operations decreases to $1.9 million

Interleukin Genetics, Inc. today announced financial and operational results for the second quarter ended June 30, 2010.

13 Aug 2010

U-M dentistry agrees to use Interleukin's PST test for gum disease clinical study

University of Michigan School of Dentistry has signed an agreement with Interleukin Genetics Inc. to conduct what may be the largest clinical study to date using genetic testing to assess the risk for gum disease.

13 Aug 2010

New criteria by ACR for early diagnosis, treatment of rheumatoid arthritis

New criteria for rheumatoid arthritis (RA), published in the Annals of Rheumatic Diseases, could prevent thousands of people from developing disabling late stage disease, by redefining how RA should be classified.Rheumatoid arthritis is a progressive autoimmune inflammatory disease, primarily of the joints. If untreated, it leads to damage of bone and cartilage, joint deformities and disability. Around 350,000 people in the UK are living with RA, which affects around three times as many women as men.

13 Aug 2010

PyroTITAN Humeral Resurfacing shoulder implant extends longevity of hemiarthroplasty joint replacement

Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic implants, announces the implantation of an additional PyroTITAN Humeral Resurfacing Implant in Brisbane, Australia. The PyroTITAN was implanted last month at the Brisbane Private Hospital.

13 Aug 2010

Bone News and Research

IVAX Diagnostics second quarter 2010 operating expenses decrease 11.9%

Study finds first clue that links childhood obesity to skeletal fractures

Orthofix launches FUSION XT knee brace with new AirTech system

NeoStem second-quarter revenues increase 26% to $19.4 million

Interleukin Genetics transfers stock trading from NYSE Amex to OTCQB Marketplace

Serum hormones, bone remodeling markers in bears could help create model for preventing osteoporosis: Study

Interventional Spine completes another successful surgery with PERPOS Percutaneous Cervical System

Exercise can ease arthritis pain

New T cell engineering approach can improve success rate of immune-cell therapies

Fertility preservation may be unsafe for leukemia patients: Study

CD31 positive cells have potential for treating peripheral artery disease: Research

Four Mass. hospitals investigate trashing of patient health records, Calif. employers worry about workers using marijuana on job

SANUWAVE second-quarter revenues decrease to $117,000

EUROPEAN BIOTECHNICA AWARD finalists announced

Benvenue Medical commences treatment in U.S. with Blazer Vertebral Augmentation System

Humanetics Corporation secures license to provide treatment for ionizing radiation exposure

Interleukin Genetics second-quarter net loss from continuing operations decreases to $1.9 million

U-M dentistry agrees to use Interleukin's PST test for gum disease clinical study

New criteria by ACR for early diagnosis, treatment of rheumatoid arthritis

PyroTITAN Humeral Resurfacing shoulder implant extends longevity of hemiarthroplasty joint replacement

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News